Diabetes technology & therapeutics
A Real-World Data Assessment of Pulmonary Toxicity of Inhaled Insulin for Diabetes.
Todd L Burstain, Irl B Hirsch, Roy W Beck
Published: 202610.1177/15209156251412816
Abstract
BACKGROUND: Inhalation of technosphere insulin (TI) has been shown to significantly reduce postmeal glucose excursions compared with injections of rapid-acting analogue (RAA) insulin in people with diabetes. However, TI has not gained widespread use…
Preview only. Read the full abstract at the source